⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BCRX

BioCryst Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

7.65USD

-0.1300 (-1.67%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BCRX.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 7.65
P/E—
Dvd Ind Yld0.0%
P/B—
P/S2.1
Curr EV/T12M EBITDA5.6
Mkt Cap (USD)2.0B
Curr EV (USD)2.4B
2)

Per Share Data

EPS T12M-1.50
DPS—
Bk Val Per Sh-1.78
Rev/Sh3.55
Cash/Sh1.38
Curr Shares Out255.5M
FCF/Sh1.41
3)

Cash Flow Analysis

P/CF5.2
Curr P/FCF5.2
CF/NI-1.0
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales40.0%
Eff Interest Rate23.6%
4)

Growth Potential

Dil EPS 1Y Gr381.4%
Cap 1Y Gr26.0%
BPS 1Y Gr76.3%
R&D To Sales21.0%
Retention Rate100.0%
Rev 1Y Gr94.1%
FCF 1Y Gr749.0%
Assets 1Y Gr4.8%
5)

Profitability

EBITDA-0.3B
EBIT-0.3B
Operating Margin-33.3%
Pretax Margin-40.5%
Net Margin-40.9%
ROA-75.8%
ROE87.8%
ROC—
Asset Turnover1.85
6)

Structure

Current Ratio2.32
Quick Ratio2.22
Debt/Assets150.0%
Debt/Com Eq-184.2%
Net Debt/EBITDA-2.19
Tot Debt/Capital218.8%
Gross Margin97.8%
EBIT/Int Exp-4.2

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.